- Home
-
Product Finder
- ACWY VAX (meningococcal polysaccharide groups A, C, W135 and Y vaccine)
- Adartrel (ropinirole)
- AeroChamber Plus* ( )
- Altargo (retapamulin)
- Ambirix (hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed))
- Amoxil (amoxicillin)
- Anectine (suxamethonium chloride)
- Arixtra (fondaparinux sodium)
- Arzerra (ofatumumab)
- Atriance (nelarabine)
- Augmentin (co-amoxiclav)
- Augmentin-Duo (co-amoxiclav (amoxicillin and clavulanic acid))
- Avamys (fluticasone furoate)
- Avodart (dutasteride)
- Bactroban (mupirocin)
- Becodisks (beclometasone dipropionate)
- Beconase (beclometasone dipropionate)
- Benlysta (belimumab)
- Betnovate (betamethasone valerate)
- Cervarix (Human Papillomavirus vaccine [Types 16, 18])
- Combodart (dutasteride 0.5 mg / tamsulosin hydrochloride 0.4mg)
- Cutivate (fluticasone propionate)
- Daraprim (pyrimethamine)
- Dermovate (clobetasol propionate)
- Engerix B (Hepatitis B (rDNA) vaccine (adsorbed) (HBV))
- Eumovate (clobetasone butyrate)
- Fendrix (hepatitis B recombinant DNA vaccine (adjuvanted, adsorbed))
- Flixonase (fluticasone propionate)
- Flixotide (fluticasone propionate)
- Flolan (epoprostenol sodium)
- Fluarix (influenza vaccine (split virion, inactivated))
- Fluarix Tetra (Influenza vaccine (split virion,inactivated)
) - Fortum (ceftazidime)
- Havrix Monodose and Havrix Junior Monodose (Hepatitis A (inactivated) vaccine (adsorbed))
- Hepatyrix (Hepatitis A (inactivated) and Typhoid Polysaccharide vaccine (adsorbed)
) - Hycamtin™ (topotecan hydrochloride)
- Imigran (sumatriptan succinate)
- Infanrix-IPV (diphtheria, tetanus, pertussis (acellular, component), and poliomyelitis vaccine)
- Integrilin* (eptifibatide)
- Lamictal® (lamotrigine)
- Liskonum (lithium carbonate)
- Malarone (atovaquone/proguanil hydrochloride)
- Menitorix (Haemophilus influenzae type b and Meningococcal group C conjugate vaccine)
- Mivacron (mivacurium chloride)
- Naramig (naratriptan hydrochloride)
- Nimbex/Nimbex Forte (cisatracurium besilate)
- Nimenrix (Meningococcal group A, C, W-135 and Y conjugate vaccine)
- Otosporin (polymyxin B sulphate, neomycin sulphate and hydrocortisone)
- Pentostam (sodium stibogluconate)
- Priorix (Combined measles, mumps and rubella vaccine)
- Prolia (denosumab)
- ReQuip (ropinirole hydrochloride)
- ReQuip XL (ropinirole hydrochloride)
- Relenza (zanamivir)
- Respontin (ipratropium bromide)
- Revolade (Eltrombopag)
- Rotarix (oral live rotavirus vaccine)
- Rupafin* (rupatadine)
- Seretide (salmeterol xinafoate/fluticasone propionate)
- Serevent (salmeterol xinafoate)
- Seroxat (paroxetine hydrochloride)
- Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed))
- Timentin (ticarcillin and clavulanic acid)
- Tracrium (atracurium besilate)
- Trimovate (clobetasone butyrate, nystatin, oxytetracycline)
- Trobalt (retigabine)
- Twinrix (hepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed))
- Typherix (vi polysaccharide typhoid vaccine)
- Tyverb (lapatinib)
- Ultiva (remifentanil hydrochloride)
- Valtrex (valaciclovir hydrochloride)
- Varilrix (varicella/chickenpox vaccine)
- Ventolin (salbutamol sulphate)
- Volibris* (ambrisentan)
- Votrient (pazopanib)
- Votrient®▼ in advanced soft tissue sarcoma (pazopanib)
- Wellvone (atovaquone)
- Zantac (ranitidine hydrochloride)
- Zinacef (cefuroxime)
- Zinnat (cefuroxime axetil)
- Zofran (ondansetron)
- Zovirax (aciclovir)
- Zyban (bupropion hydrochloride)
- amoxicillin (Amoxil)
- atovaquone/proguanil hydrochloride (Malarone)
- atracurium besilate (Tracrium)
- ambrisentan (Volibris*)
- atovaquone (Wellvone)
- aciclovir (Zovirax)
- beclometasone dipropionate (Becodisks)
- beclometasone dipropionate (Beconase)
- belimumab (Benlysta)
- betamethasone valerate (Betnovate)
- bupropion hydrochloride (Zyban)
- co-amoxiclav (Augmentin)
- co-amoxiclav (amoxicillin and clavulanic acid) (Augmentin-Duo)
- clobetasol propionate (Dermovate)
- clobetasone butyrate (Eumovate)
- ceftazidime (Fortum)
- cisatracurium besilate (Nimbex/Nimbex Forte)
- Combined measles, mumps and rubella vaccine (Priorix)
- clobetasone butyrate, nystatin, oxytetracycline (Trimovate)
- cefuroxime (Zinacef)
- cefuroxime axetil (Zinnat)
- dutasteride (Avodart)
- dutasteride 0.5 mg / tamsulosin hydrochloride 0.4mg (Combodart)
- diphtheria, tetanus, pertussis (acellular, component), and poliomyelitis vaccine (Infanrix-IPV)
- denosumab (Prolia)
- epoprostenol sodium (Flolan)
- eptifibatide (Integrilin*)
- Eltrombopag (Revolade)
- fondaparinux sodium (Arixtra)
- fluticasone furoate (Avamys)
- fluticasone propionate (Cutivate)
- fluticasone propionate (Flixonase)
- fluticasone propionate (Flixotide)
- hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) (Ambirix)
- Human Papillomavirus vaccine [Types 16, 18] (Cervarix)
- Hepatitis B (rDNA) vaccine (adsorbed) (HBV) (Engerix B)
- hepatitis B recombinant DNA vaccine (adjuvanted, adsorbed) (Fendrix)
- Hepatitis A (inactivated) vaccine (adsorbed) (Havrix Monodose and Havrix Junior Monodose)
- Hepatitis A (inactivated) and Typhoid Polysaccharide vaccine (adsorbed)
(Hepatyrix) - Haemophilus influenzae type b and Meningococcal group C conjugate vaccine (Menitorix)
- hepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed) (Twinrix)
- influenza vaccine (split virion, inactivated) (Fluarix)
- Influenza vaccine (split virion,inactivated)
(Fluarix Tetra) - ipratropium bromide (Respontin)
- lamotrigine (Lamictal®)
- lithium carbonate (Liskonum)
- lapatinib (Tyverb)
- meningococcal polysaccharide groups A, C, W135 and Y vaccine (ACWY VAX)
- mupirocin (Bactroban)
- mivacurium chloride (Mivacron)
- Meningococcal group A, C, W-135 and Y conjugate vaccine (Nimenrix)
- nelarabine (Atriance)
- naratriptan hydrochloride (Naramig)
- ofatumumab (Arzerra)
- oral live rotavirus vaccine (Rotarix)
- ondansetron (Zofran)
- pyrimethamine (Daraprim)
- polymyxin B sulphate, neomycin sulphate and hydrocortisone (Otosporin)
- paroxetine hydrochloride (Seroxat)
- pneumococcal polysaccharide conjugate vaccine (adsorbed) (Synflorix)
- pazopanib (Votrient)
- pazopanib (Votrient®▼ in advanced soft tissue sarcoma)
- ropinirole (Adartrel)
- retapamulin (Altargo)
- ropinirole hydrochloride (ReQuip)
- ropinirole hydrochloride (ReQuip XL)
- rupatadine (Rupafin*)
- retigabine (Trobalt)
- remifentanil hydrochloride (Ultiva)
- ranitidine hydrochloride (Zantac)
- suxamethonium chloride (Anectine)
- sumatriptan succinate (Imigran)
- sodium stibogluconate (Pentostam)
- salmeterol xinafoate/fluticasone propionate (Seretide)
- salmeterol xinafoate (Serevent)
- salbutamol sulphate (Ventolin)
- topotecan hydrochloride (Hycamtin™)
- ticarcillin and clavulanic acid (Timentin)
- vi polysaccharide typhoid vaccine (Typherix)
- valaciclovir hydrochloride (Valtrex)
- varicella/chickenpox vaccine (Varilrix)
- zanamivir (Relenza)
- News
This site is controlled and operated by GlaxoSmithKline UK Limited (GSK) from its offices in the UK. This website has a specific section for members of the public, a specific section for patients and a specific section for healthcare professionals.
“Healthcare professional” includes members of the medical, dental, pharmacy and nursing professions and other persons who in the course of their professional activities may prescribe, supply or administer a medicine and associated, appropriate, administrative staff.
The section for the public has been designed as a library resource to provide reference information relating to GSK medicines, including but not limited to, prescription only medicines, to the public within UK. Within the public section there are specific patient-only pages for those who have been prescribed the medicine relating to those pages. These pages remain hidden from site navigation and can only be accessed once a member of the public has confirmed they are a patient that has been prescribed a particular medicine.
NO WARRANTY
GSK makes no representation that material in the site is appropriate or available for use outside of the UK. Those who choose to access this site from other locations do so on their own initiative and are responsible for compliance with local laws, if and to the extent that local laws are applicable.
GSK uses reasonable efforts to update the website, but makes no representation or warranty in respect of accuracy or lack of errors.
Use of the site is at the risk of the user. GSK takes no responsibility for direct, indirect or consequential loss from use of this site and all implied warranties are excluded to the extent permissible under English law.
GSK accepts no liability for viruses infecting the user following its use of the audio, video, data or text on the site.
HEALTHCARE INFORMATION
While every effort has been made to ensure that healthcare information on this website is correct and up to date, the advice given on this website is of a general nature only and GSK makes no claims or warranties as to its accuracy, or usefulness.
Specific medical advice should always be sought from a qualified medical practitioner.
FOR HEALTHCARE PROFESSIONALS ONLY : Please note that approved prescribing information must guide the appropriate use of all medicines. Before prescribing any medicine, healthcare professionals should consult the approved prescribing information for that medicine in their country.
INTELLECTUAL PROPERTY
All material on this site is © Copyright 2012, GlaxoSmithKline group of companies, or they have been granted permission to use such material except where specifically stated otherwise. Reproduction of part or all of the contents in any form is prohibited other than in accordance with the following permissions.
Licence to copy for personal use
You may read, view, print, download and copy the material on this website for your personal, non-commercial use only but only if in any copy of the material you acknowledge the web page as the source of the material and include the copyright statement “© Copyright 2001 - 2012, GlaxoSmithKline group of companies”.
This licence does not permit incorporation of the material or any part of it in any other work or publication, whether in hard copy or electronic or any other form. In particular (but without limitation) no part of the material from this website may be distributed or copied for any commercial purpose.
No part of the site may be reproduced on or transmitted to or stored in any other web site or other form of electronic retrieval system.
Nothing contained in this website should be construed as conferring, by implication or otherwise:
(i) any licence or right under any patent or trademark of the GlaxoSmithKline group of companies or any third party; or
(ii) except as expressly provided in these Terms of Use, any licence or right under any copyright of the GlaxoSmithKline group of companies
TRADE MARKS
Trade marks owned by or licensed to the GlaxoSmithKline group of companies are indicated by an appropriate trade mark symbol, or are set off from surrounding text (for example by use of italics, bold or capital letters). Trade marks are also highlighted at the foot of main pages.
Where trade marks owned by third parties appear on this website, GlaxoSmithKline claims no ownership in, nor any affiliation with, the third party owner of such trade marks. Such third party trade marks are used only to identify the products and services of their respective owners, and no sponsorship or endorsement by GlaxoSmithKline should be inferred from the use of these marks.
HYPERTEXT LINKS
Certain hypertext links in this website will lead you to sites which are not under the control of GSK. When you activate any of these, you will leave the site.
GSK accepts no responsibility or liability for the contents of any third party site to which a hypertext link exists and gives no representation or warranty (express or implied) as to the information contained on such sites.
GSK has no control over the nature and contents of such sites and is not recommending those sites, the information they contain nor any third party's products or services.
Please ensure you read the legal and privacy policy sections of any other GSK or third party site you link to.
USE OF INFORMATION
Communications from users (other than personal or health related information which is covered by GSK’s Privacy Policy) are treated as non-confidential and non-proprietary and GSK can use the information for any purpose, including reproduction and publication, and can use the ideas communicated for any purpose, including commercial ones.
JURISDICTION
These Terms of Use and the content of this site shall be governed by English law.
CHANGES
These Terms of Use may be revised at any time so the user is advised to check them regularly.
LAST UPDATED : December 2012
UK/COM/0060/12(1)